We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+353.09%
AUM
$967M
AUM Growth
+$34.1M
Cap. Flow
+$3.02M
Cap. Flow %
0.31%
Top 10 Hldgs %
21.2%
Holding
258
New
9
Increased
107
Reduced
75
Closed
9

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$12.7M
2
NXPI icon
NXP Semiconductors
NXPI
+$7.19M
3
MET icon
MetLife
MET
+$5.66M
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$2.39M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$1.8M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$7.68M
2
KO icon
Coca-Cola
KO
+$6.98M
3
EMC
EMC CORPORATION
EMC
+$5.89M
4
WBA
Walgreens Boots Alliance
WBA
+$2.75M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$2.52M

Sector Composition

Rank Sector Weight
1 Healthcare 20.02%
2 Industrials 15.05%
3 Technology 12.15%
4 Consumer Staples 9.68%
5 Energy 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMT icon
51
Walmart Inc
WMT
$884B
$7.52M 0.78%
300,471
+3,150
+1% +$80.9K
EBAY icon
52
eBay
EBAY
$50.4B
$7.33M 0.76%
347,709
-12,457
-3% -$271K
IBM icon
53
IBM
IBM
$209B
$7.2M 0.74%
41,552
-1,447
-3% -$260K
NVS icon
54
Novartis
NVS
$301B
$6.54M 0.68%
80,632
+2,299
+3% +$181K
MDY icon
55
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$6.23M 0.64%
23,915
+150
+0.6% +$37.6K
APH icon
56
Amphenol
APH
$197B
$6.12M 0.63%
507,912
+3,840
+0.8% +$45.8K
SLXP
57
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$6.01M 0.62%
48,725
+16,300
+50% +$1.8M
JPM icon
58
JPMorgan Chase
JPM
$933B
$5.96M 0.62%
103,426
+821
+0.8% +$46.2K
K
59
DELISTED
Kellanova
K
$5.91M 0.61%
95,781
+400
+0.4% +$25K
ABBV icon
60
AbbVie
ABBV
$455B
$5.86M 0.61%
103,866
-550
-0.5% -$28.9K
SRCL
61
DELISTED
Stericycle Inc
SRCL
$5.85M 0.61%
49,430
+260
+0.5% +$29.8K
AMZN icon
62
Amazon
AMZN
$2.53T
$5.82M 0.6%
358,080
+13,020
+4% +$206K
KSS icon
63
Kohl's
KSS
$2.21B
$5.79M 0.6%
109,883
-2,035
-2% -$110K
EMC
64
DELISTED
EMC CORPORATION
EMC
$5.2M 0.54%
197,521
-223,218
-53% -$5.89M
GWW icon
65
W.W. Grainger
GWW
$64B
$5.18M 0.54%
20,385
-480
-2% -$123K
MA icon
66
Mastercard
MA
$510B
$5.09M 0.53%
69,250
+1,450
+2% +$108K
PX
67
DELISTED
Praxair Inc
PX
$4.66M 0.48%
35,084
+95
+0.3% +$12.4K
IBB icon
68
iShares Biotechnology ETF
IBB
$9.52B
$4.61M 0.48%
53,805
+180
+0.3% +$14.2K
NTRS icon
69
Northern Trust
NTRS
$22.4B
$4.51M 0.47%
70,209
-6,550
-9% -$404K
ICE icon
70
Intercontinental Exchange
ICE
$87.7B
$4.48M 0.46%
118,500
-21,865
-16% -$852K
J icon
71
Jacobs Solutions
J
$15.7B
$4.35M 0.45%
98,722
+1,447
+1% +$68.9K
PG icon
72
Procter & Gamble
PG
$335B
$4.25M 0.44%
54,118
+906
+2% +$73.1K
COST icon
73
Costco
COST
$423B
$4.19M 0.43%
36,365
+333
+0.9% +$38.2K
MRK icon
74
Merck
MRK
$321B
$4.18M 0.43%
75,761
+3,740
+5% +$204K
T icon
75
AT&T
T
$159B
$4.04M 0.42%
151,086
+22,810
+18% +$611K
1 2
3
4 5

Similar funds

GWP
Gateway Wealth Partners Appleton, Wisconsin $2.57B AUM 16.81% 1-Year Est. Return
PCM
Palestra Capital Management New York $2.57B AUM 29.93% 1-Year Est. Return
DCM
Dorsal Capital Management Redwood City, California $2.57B AUM 3.13% 1-Year Est. Return
RG
Rakuten Group Setagaya-Ku, Tokyo, Japan $2.58B AUM 250.19% 1-Year Est. Return
GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return
LS
Livforsakringsbolaget Skandia Stockholm, Sweden $2.58B AUM 30.64% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

Chesley Taft & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Chesley Taft & Associates held 258 positions worth $967M, up 3.7% from $933M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Chesley Taft & Associates's Q2 2014 filing shows 9 new, 107 increased, 75 reduced and 9 closed positions. Its largest new stake was NXP Semiconductors: 117,465 shares worth $7.77M. The largest sale was CR Bard Inc., an estimated $7.68M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

  • Chesley Taft & Associates's largest Q2 2014 buy was NXP Semiconductors: 117,465 shares worth $7.77M.
  • Chesley Taft & Associates added most to Celgene Corp in Q2 2014, an estimated $12.7M increase.
  • Chesley Taft & Associates's biggest Q2 2014 reduction was Coca-Cola, cutting an estimated $6.98M.
  • Chesley Taft & Associates fully exited CR Bard Inc. in Q2 2014, selling an estimated $7.68M.
  • Chesley Taft & Associates's ten largest holdings make up 21% of its $967M portfolio in Q2 2014.
  • Chesley Taft & Associates opened 9 new positions and closed 9 in Q2 2014.
  • Chesley Taft & Associates's portfolio value rose 3.7% quarter-over-quarter to $967M.

Based on Chesley Taft & Associates's 13F filing for Q2 2014, filed 17 Jul 2014.